Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study

ABSTRACT Background Patients with decompensated cirrhosis have a higher risk of hospitalization, ICU admission, and death from COVID‐19. The impact of demographics on these outcomes remains uncertain. Methods The SECURE‐Liver and COVID‐Hep databases were utilized to evaluate disparities in COVID‐19...

Full description

Saved in:
Bibliographic Details
Published in:JGH open 2024-12, Vol.8 (12), p.e70064-n/a
Main Authors: Hayat, Umar, Moon, Andrew M., Gangwani, Manesh K., Hasan, Fariha, Marjot, Thomas, Barritt, A. Sidney, Mirza, Wasique, Deivert, Duane, Aziz, Muhammad, Dahiya, Dushyant Singh, Ali, Hassam, Inamdar, Sumant, Garcia‐Saenz‐de‐Sicilia, Mauricio
Format: Article
Language:English
Subjects:
COVID-19
COVID‐Hep
decompensated cirrhosis
Fatalities
Mortality
Original
Pandemics
racial disparities
SECURE‐Liver
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Background Patients with decompensated cirrhosis have a higher risk of hospitalization, ICU admission, and death from COVID‐19. The impact of demographics on these outcomes remains uncertain. Methods The SECURE‐Liver and COVID‐Hep databases were utilized to evaluate disparities in COVID‐19 outcomes. Patients were stratified by North American and European cohorts. Bivariate and multivariable logistic regression was performed. Results A total of 718 cirrhosis patients with COVID‐19 were evaluated. In the North American cohort, Black patients had more comorbidities (CI: 1.86 vs. 1.83, p 
ISSN:2397-9070
2397-9070
DOI:10.1002/jgh3.70064